serum glutathion reductas cystic fibrosi serum glutathion reductas nadphgssg oxidoreductas ec 1642 gr examin cystic fibrosi subject cf oblig cf heterozygot control subject serum protein concentr similar three group regardless unit use express activ milligram protein millilit serum whether sampl dialyz water phosphat buffer mean serum gr cf greater control subject p less equal 0002 seri sever year assay condit differ serum gr control subject carrier detect calcul assay valu combin control cf sera agre expect observ 50 activ 12 sera dilut cf control subject carrier addit fad incub media effect enzym activ three group differ cf control subject persist dialysi membran permit passag molecul approxim 12000 mol wt less find would tend exclud effect extran serum factor explain differ cf control subject percentag initi gr activ four day storag 04 degre significantli greater cf control subject p less 0025 effect heparin serum gr record percentag activ incub heparin vs activ standard assay individu subject effect incub 5 mugml heparin serum gr activ greater control subject carrier p less 00005 cf p less 00005 mean serum gr activ cf carrier unaffect heparin wherea mean activ control subject decreas control percentag initi activ heparin greater mean cf carrier group 3 20 cf 4 20 carrier individu percentag lower control mean cf carrier distribut clearli differ control distribut serum gr determin seven noncf individu chronic obstruct pulmonari diseas copd activ copd differ cf differ control subject none control copd serum gr great cf mean serum gr cf low mean control subject copd conclud serum gr activ greater cf control subject carrier noncf copd subject differ activ attribut extran serum factor activ differ secondari chronic respiratori diseas comparison control subject gr cf serum behav differ storag serum gr cf carrier behav differ control gr presenc heparin